EP2381803B1 - Smokeless dissolvable compressed tobacco product - Google Patents
Smokeless dissolvable compressed tobacco product Download PDFInfo
- Publication number
- EP2381803B1 EP2381803B1 EP09812420.9A EP09812420A EP2381803B1 EP 2381803 B1 EP2381803 B1 EP 2381803B1 EP 09812420 A EP09812420 A EP 09812420A EP 2381803 B1 EP2381803 B1 EP 2381803B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tobacco
- component
- pasteurised
- dissolvable compressed
- smokeless dissolvable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000019505 tobacco product Nutrition 0.000 title claims description 71
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 113
- 241000208125 Nicotiana Species 0.000 claims description 112
- 238000000034 method Methods 0.000 claims description 35
- 239000011230 binding agent Substances 0.000 claims description 13
- 239000000796 flavoring agent Substances 0.000 claims description 13
- 239000000314 lubricant Substances 0.000 claims description 11
- 230000000181 anti-adherent effect Effects 0.000 claims description 10
- 239000003911 antiadherent Substances 0.000 claims description 10
- 239000000945 filler Substances 0.000 claims description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- 238000010793 Steam injection (oil industry) Methods 0.000 claims description 6
- 239000003349 gelling agent Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000000813 microbial effect Effects 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 239000004267 EU approved acidity regulator Substances 0.000 claims description 4
- 239000003623 enhancer Substances 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 239000003765 sweetening agent Substances 0.000 claims description 4
- 239000006172 buffering agent Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000004186 food analysis Methods 0.000 claims description 3
- 239000007884 disintegrant Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229960002715 nicotine Drugs 0.000 description 4
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920000881 Modified starch Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000008122 artificial sweetener Substances 0.000 description 3
- 235000021311 artificial sweeteners Nutrition 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 150000005846 sugar alcohols Chemical class 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- -1 for example Substances 0.000 description 2
- 229910021485 fumed silica Inorganic materials 0.000 description 2
- 239000000905 isomalt Substances 0.000 description 2
- 235000010439 isomalt Nutrition 0.000 description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 2
- 239000000832 lactitol Substances 0.000 description 2
- 235000010448 lactitol Nutrition 0.000 description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 2
- 229960003451 lactitol Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 238000009928 pasteurization Methods 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000911175 Citharexylum caudatum Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 235000015164 Iris germanica var. florentina Nutrition 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 241000208134 Nicotiana rustica Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 244000182022 Salvia sclarea Species 0.000 description 1
- 235000002911 Salvia sclarea Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 239000004965 Silica aerogel Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000020053 arrack Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- PASHVRUKOFIRIK-UHFFFAOYSA-L calcium sulfate dihydrate Chemical compound O.O.[Ca+2].[O-]S([O-])(=O)=O PASHVRUKOFIRIK-UHFFFAOYSA-L 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 235000020057 cognac Nutrition 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 239000001939 cymbopogon martini roxb. stapf. oil Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical class CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000013531 gin Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 244000023249 iris florentino Species 0.000 description 1
- 239000000177 juniperus communis l. berry Substances 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 229940037627 magnesium lauryl sulfate Drugs 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000012243 magnesium silicates Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- WEOPSTWALVBTPP-UHFFFAOYSA-N molecular chlorine;propane-1,2,3-triol Chemical compound ClCl.OCC(O)CO WEOPSTWALVBTPP-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229930187593 rose bengal Natural products 0.000 description 1
- 229940081623 rose bengal Drugs 0.000 description 1
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000013533 rum Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 229940045902 sodium stearyl fumarate Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/183—Treatment of tobacco products or tobacco substitutes sterilization, preservation or biological decontamination
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/20—Biochemical treatment
Definitions
- the present invention relates to a method of making a smokeless dissolvable compressed tobacco product.
- a number of oral smokeless non-dissolvable tobacco products that include an insoluble residual component that is disposed of by a consumer after use are known in the art.
- Known smokeless non-dissolvable tobacco products include: plug, twist, and loose leaf chewing tobacco; dry snuff; moist snuff, which typically contains finely cut fermented moist tobacco; loose or portioned snus, which typically contains finely ground moist tobacco; and tobacco-containing chewing gum.
- a number of oral smokeless dissolvable tobacco products that dissolve in the mouth of a consumer are also known.
- smokeless dissolvable compressed tobacco products in the form of pills, tablets and lozenges which comprise powdered or ground tobacco together with other ingredients.
- GB 2 142 822 A discloses nicotine containing lozenges prepared from a mixture of inert filler material, a binder and either pure nicotine or a nicotine containing substance by a technique not involving any application of heat.
- WO 2007/138484 A discloses a method of making film strips by casting or extruding a liquid mixture comprising one or more tobacco components, one or more binders, one or more humectants and optionally one or more flavorants and then drying the cast or extruded film.
- the tobacco can be pasteurized by any suitable technique.
- the tobacco component can be pasteurized by high pressure, heat and/or steam.
- Raw, unprocessed tobacco may contain increased levels of viable bacteria, As smokeless dissolvable compressed tobacco products dissolve and the tobacco in such products is ingested by the consumer, it would be desirable to provide an improved method for treating a smokeless dissolvable compressed tobacco product for oral use.
- a method of making a smokeless dissolvable compressed tobacco product comprising: pasteurising a tobacco component to reduce the total aerobic microbial count to less than 2 log cfu/g and the total yeast and mould count to less than 2 log cfu/g; mixing the pasteurised tobacco component with one or more non-tobacco components; and compressing the pasteurised tobacco component and one or more non-tobacco components to form a smokeless dissolvable compressed tobacco product.
- the step of pasteurising the tobacco component comprises direct heating of the tobacco by hot steam injection to a temperature of between about 100°C and about 120°C for a period of between about 1 minute and about 30 minutes.
- the total aerobic microbial count is measured in accordance with the Nordic Committee on Food Analysis (NMKL) method No 86, 4. Ed., 2006 and the total yeast and mould count specified is measured in accordance with NMKL method No 98, 4. Ed., 2005 .
- the NMKL method No 86, 4. Ed., 2006 is used to determine the aerobic plate count by preparing a dilution series of sample material according to general microbiological principles, followed by pour-plating into an agar medium in Petri dishes, In this method, the samples are incubated under aerobic conditions at either 30°C for 3 days, 20°C for 3 days, or 6.5°C for 10 days.
- the tobacco component may be pasteurised using any suitable technique provided that the pasteuriation parameters such as temperature and time are sufficient to reduce the total aerobic microbial count of the tobacco component to less than 2 log cfu/g and the total yeast and mold count of the tobacco component to less than 2 log cfu/g to render the tobacco component substantially aseptic.
- Suitable pasteurisation techniques include, but are not limited to, single hot steam injection and repeated hot steam injection
- the step of pasteurising the tobacco component comprises direct heating of the tobacco by hot steam injection to a temperature of between about 100°C and about 120°C for a period of between about 1 minute and about 30 minutes. More preferably, the step of pasteurising the tobacco component comprises direct heating of the tobacco component by repeated hot steam injection to temperatures of at least about 100°C.
- the heat treament of the tobacco component during pasteurisation advantageously results in the formation of tobacco-derived flavourings.
- the tobacco component may be pasteurised together with water.
- the tobacco component may be pasteurised with one or more other additives approved for use in the food industry, including, but not limited to, sodium chloride, sodium carbonate, potassium carbonate, propylene glycol, glycerol and combinations thereof.
- the pH of the pasteurised tobacco component may be adjusted prior to compressing the pasteurised tobacco component and one or more non-tobacco components to form the smokeless dissolvable compressed tobacco product.
- the pH of the pasteurised tobacco component is adjusted to between about 7.5 and about 8.9.
- the pH of the pasteurised tobacco component may be adjusted through the addition of one or more acidity regulators.
- Suitable acidity regulators approved for use in the food industry are known in the art and include, but are not limited to: alkali carbonates, such as sodium carbonate and potassium carbonate; calcium carbonate; alkali hydroxides, such as sodium hydroxide and potassium hydroxide; calcium hydroxide; magnesium hydroxide; and combinations thereof.
- the pH of the pasteurised tobacco component is adjusted prior to mixing the pasteurised tobacco component with the one or more non-tobacco components.
- the pH of the pasteurised tobacco component may be adjusted by mixing the pasteurised tobacco component with one or more non-tobacco components comprising at least one acidity regulator or buffering agent.
- the tobacco component may comprise one or more of tobacco lamina, tobacco stem, expanded tobacco and reconstituted tobacco.
- the tobacco component may comprise a blend of two or more different types of tobacco.
- the tobacco component may comprise a blend of two or more of different types of tobacco selected from the group consisting of Virginia, Burley, Maryland, Nicotiana rustica and oriental tobacco.
- the tobacco component may comprise a single type of tobacco.
- the tobacco component may comprise tobacco that has been one or more of dried, aged, flue-cured, air-cured, fire-cured, sun-cured, shredded, powdered and ground.
- the tobacco component comprises air-cured tobacco, sun-cured tobacco, dark air-cured tobacco or a combination thereof.
- the tobacco component comprises particulate tobacco. More preferably, the tobacco component comprises powdered tobacco, ground tobacco or a combination thereof.
- the particulate tobacco may have any suitable average particle size.
- the particulate tobacco may have an average particle size of less than about 1 mm, less than about 0.5 mm or less than about 0.1 mm.
- the particulate tobacco has an average particle size of between about 100 nm and about 1 mm, more preferably of between about 100 nm and about 0.5 mm.
- the tobacco may be ground and sieved in a typical manner in order to obtain a desired particle size.
- smokeless dissolvable compressed tobacco products made by methods according to the invention further comprise one or more non-tobacco components.
- smokeless dissolvable compressed tobacco products made by methods according to the invention may further comprise one or more non-tobacco components approved for use in the food industry selected from the group consisting of: acidity regulators, buffering agents, fillers, binders, gelling agents, lubricants, anti-adherents, glidants, disintegration agents, sweeteners, flavourants, taste enhancers and colourants.
- the pasteurised tobacco component may be dry blended or otherwise mixed with the one or more non-tobacco components.
- the tobacco component and one or more non-tobacco components may be ground together or mixed in a twisting powder mixer.
- the tobacco component may be present in the smokeless dissolvable compressed tobacco product in an amount of between about 0.5% to about 60% of the dry weight of the compressed tobacco product.
- the amount of the tobacco component may be selected as a function of, for example, the desired nicotine content or the desired flavour or other organoleptic properties of the smokeless dissolvable compressed tobacco product.
- the smokeless dissolvable compressed tobacco product comprises: at least one binder or filler; at least one lubricant, anti-adherent or glidant; at least one acidity regulator; at least one flavourant; and at least one sweetener.
- the smokeless dissolvable compressed tobacco product also comprises one or more of a gelling agent, a taste enhancer, a colourant and a disintegration agent.
- the smokeless dissolvable compressed tobacco product comprises at least one binder or filler.
- the smokeless dissolvable compressed tobacco product may optionally comprise one or more gelling agents.
- gelling agent is used to refer to any component that affects the mouth feel of the smokeless dissolvable compressed tobacco product when dissolved in the mouth of a consumer.
- Suitable binders, fillers and gelling agents include, but are not limited to: non-tobacco plant fibres; starches, including pre-gelatinized starch; gums, including natural gums, such as xanthan gum, gum, acacia, gum arabic, guar gum, locust bean gum and sodium alginate; pectins: gelatine: agar: carrageenan; pullulan; microcrystalline cellulose; methyl cellulose; carboxymethyl cellulose; dextrins, including maltodextrin; sugar alcohols, such as erythritol, xylitol mannitol, sorbitol, isomalt, maltitol and lactitol; glucose; lactose; sucrose; polyvidone; calcium sulfate dihydrate; and combinations thereof.
- non-tobacco plant fibres starches, including pre-gelatinized starch
- gums including natural gums, such as xanthan gum, gum,
- the smokeless dissolvable compressed tobacco product comprises microcrystalline cellulose, which functions as a binder and a filler.
- the smokeless dissolvable compressed tobacco product may optionally comprise one or more lubricants, anti-adherents, glidants or combinations thereof.
- lubricant anti-adherent and glidant are used to refer to any component that facilitates manufacturing of the smokeless dissolvable compressed tobacco product by reducing friction, reducing adhesion, or otherwise improving flow properties. It will be appreciated that a single non-tobacco component may perform the functions of one or more of a lubricant, an anti-adherent and a glidant.
- Suitable lubricants, anti-adherents and glidants include, but are not limited to: stearates, including magnesium stearate, calcium stearate, sodium stearate, zinc stearate, and derivatives thereof, including sodium stearyl fumarate; fatty acids, including stearic acid; silicates, including magnesium silicates and calcium silicates; starch; lauryl sulfates, including magnesium lauryl sulfate and sodium lauryl sulfate; polyethylene glycol; and silica aerogels, including colloidal fumed silica.
- the one or more lubricants, anti-adherents, glidants or combinations thereof may be present in the smokeless dissolvable compressed tobacco product in an amount of, for example, between about 0.1% to about 5% of the dry weight of the compressed tobacco product.
- the one or more lubricants, anti-adherents, glidants or combinations thereof are present in the smokeless dissolvable compressed tobacco product in an amount of less than about 1% of the dry weight of the compressed tobacco product, more preferably in an amount of about 0.2% of the dry weight of the compressed tobacco product.
- the smokeless dissolvable compressed tobacco product may optionally comprise one or more disintegrants.
- disintegrant is used to refer to any component that facilitates breakup or disintegration of the smokeless dissolvable compressed tobacco product when placed in a consumer's mouth.
- Suitable disintegrants include, but are not limited to: starches, including pregelatinised starch; sodium starch glycolate; sodium alginate; croscarmellose sodium; crosslinked polyvinylpyrrolidone, including crospovidone; sodium carboxymethyl cellulose; calcium carboxymethyl cellulose; sodium bicarbonate; and calcium carbonate.
- the one or more disintegrants maybe present in the smokeless dissolvable compressed tobacco product in an amount of, for example, between about 1% to about 15% of the dry weight of the compressed tobacco product.
- the smokeless dissoluble compressed tobacco product may optionally comprise one or more sweeteners.
- Smokeless dissolvable compressed tobacco products made by methods according to the invention may include natural sweeteners, artificial sweeteners or combinations thereof.
- Suitable natural and artificial sweeteners are known in the art and include, but are not limited to: monosaccharides, such as glucose, fructose, ribose xylose and invert sugar; disaccharides, such as lactose, maltose and sucrose; sugar alcohols, such as erythritol, xylitol mannitol, sorbitol, isomalt, maltitol and lactitol; and artificial sweeteners, such as sucralose, aspartame, saccharin, acesulfame K, and cyclamate,
- Smokeless dissolvable compressed tobacco products made by methods according to the invention may optionally comprise one or more flavourants.
- Smokeless dissolvable compressed tobacco products made by methods according to the invention may include natural flavourants, artificial flavourants or combinations thereof.
- the one or more flavourants may be added in encapsulated or non-encapsulated form.
- Suitable natural and artificial flavourants include, but are not limited to, peppermint, spearmint, wintergreen, menthol, eucalyptus oil, angelica, anise, anethole, carvone, vanillin, vanilla, basil oil, cardamom, cassia, cinnamon, clove, cocoa, coriander oil, fennel oil, fenugreek, ginger, lemon grass, liquorice, nutmeg, palmarosa oil, sage oil, acacia, amber, clary, geranium, jasmine, juniper berry, lavender oil, magnolia, oak moss, orris root, osmanthus, rose oil, sandalwood, bergamot oil, lemon oil, lime oil, orange oil, fruit extracts, fruit flavouring, almond, coconut, chocolate, coffee, tea, arrack, rum, cognac, whisky, and gin.
- the one or more flavourants may be present in the smokeless dissolvable compressed tobacco product in an amount of, for example, between about 0.1% to about 4% of the dry weight of the compressed tobacco product.
- Smokeless dissolvable compressed tobacco products made by methods according to the invention may optionally comprise one or more taste enhancers such as, for example, sodium chloride or ammonium chloride.
- Smokeless dissolvable compressed tobacco products made by methods according to the invention may optionally comprise one or more colourants to, for example, indicate or reflect the flavour or brand of the compressed tobacco product or otherwise enhance its aesthetic appearance.
- smokeless dissolvable compressed tobacco products made by methods according to the invention may comprise multifunctional non-tobacco components that perform two or more of the functions previously described above.
- the smokeless dissolvable compressed tobacco product may comprise a multifunctional non-tobacco component that functions as at least two of: (i) a binder or filler; (ii) a lubricant, anti-adherent or glidant; and (iii) a disintegrant.
- the smokeless dissolvable compressed tobacco product may comprise pre-gelatinised starch that functions as a binder, lubricant and disintegrant.
- Smokeless dissolvable compressed tobacco products made by methods according to the invention may also comprise mutlifunctional non-tobacco components that perform two or more other functions.
- the smokeless dissolvable compressed tobacco product may comprise a sugar alcohol that acts as a binder and a sweetner, or colloidal fumed silica that acts as a glidant and a desiccant.
- Other suitable known desiccants such as, for example, magnesium sulfate may also be included in smokeless dissolvable compressed tobacco products made by methods according to the invention to control the moisture content thereof.
- the pasteurised tobacco component may be dry blended with one or more non-tobacco components and then directly compressed in a typical manner to form the smokeless dissolvable compressed tobacco product.
- the pasteurised tobacco component and one or more non-tobacco components maybe be directly compressed using, for example, a tablet press having a single die and punch arrangement or a rotary tablet press having multiple dies.
- the pasteurised tobacco component may optionally be wet granulated in a typical manner using, for example, a fluid bed granulator.
- the compression forces used to form the smokeless dissolvable compressed tobacco product may be selected based on a number of factors. These factors include: the type of apparatus employed to compress the tobacco component and one or more non-tobacco components; the size of the smokeless dissolvable compressed tobacco product; the desired physical and mechanical properties of the smokeless dissolvable compressed tobacco product, including but not limited to the hardness, friability, disintegration or dissolution characteristics; and the desired appearance of the compressed smokeless dissolvable compressed tobacco product.
- smokeless dissolvable compressed tobacco products may be made by methods according to the invention having a hardness of between about 2 N and about 300 N.
- smokeless dissolvable compressed tobacco products may be made by methods according to the invention that dissolve in the mouth of an average consumer within about 5 minutes to about 45 minutes.
- smokeless dissolvable compressed tobacco products may be made by methods according to the invention that dissolve in the mouth of an average consumer within about 5 minutes to about 15 minutes.
- smokeless dissolvable compressed tobacco products may be made by methods according to the invention which dissolve in the mouth of an average consumer within about 30 minutes to about 45 minutes and which can be sucked by a consumer and then "parked" between their cheek and gum.
- one or more surfaces of the formed smokeless dissolvable compressed tobacco product may be embossed or debossed.
- the formed smokeless dissolvable compressed tobacco product may be at least partially coated in a typical manner using, for example, a pan coater.
- Smokeless dissolvable compressed tobacco products may be made by methods according to the invention in a variety of different shapes.
- Figs. 1-12 show: (a) perspective views; (b) side views; and (c) top views of examples of different shaped smokeless dissolvable compressed tobacco products that may be made by methods according to the invention.
- Smokeless dissolvable compressed tobacco products may also be made by methods according to the invention in a variety of different sizes.
- smokeless dissolvable compressed tobacco products made by methods according to the invention may have a diameter of from about 2 mm to about 30 mm and a weight of from about 0.1 g to about 3.0 g.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Manufacture Of Tobacco Products (AREA)
Description
- The present invention relates to a method of making a smokeless dissolvable compressed tobacco product.
- A number of oral smokeless non-dissolvable tobacco products that include an insoluble residual component that is disposed of by a consumer after use are known in the art. Known smokeless non-dissolvable tobacco products include: plug, twist, and loose leaf chewing tobacco; dry snuff; moist snuff, which typically contains finely cut fermented moist tobacco; loose or portioned snus, which typically contains finely ground moist tobacco; and tobacco-containing chewing gum.
- A number of oral smokeless dissolvable tobacco products that dissolve in the mouth of a consumer are also known. Amongst these are smokeless dissolvable compressed tobacco products in the form of pills, tablets and lozenges, which comprise powdered or ground tobacco together with other ingredients.
-
GB 2 142 822 A -
WO 2007/138484 A discloses a method of making film strips by casting or extruding a liquid mixture comprising one or more tobacco components, one or more binders, one or more humectants and optionally one or more flavorants and then drying the cast or extruded film. Optionally, the tobacco can be pasteurized by any suitable technique. For example, the tobacco component can be pasteurized by high pressure, heat and/or steam. - Raw, unprocessed tobacco may contain increased levels of viable bacteria, As smokeless dissolvable compressed tobacco products dissolve and the tobacco in such products is ingested by the consumer, it would be desirable to provide an improved method for treating a smokeless dissolvable compressed tobacco product for oral use.
- According to the Invention there is provided a method of making a smokeless dissolvable compressed tobacco product comprising: pasteurising a tobacco component to reduce the total aerobic microbial count to less than 2 log cfu/g and the total yeast and mould count to less than 2 log cfu/g; mixing the pasteurised tobacco component with one or more non-tobacco components; and compressing the pasteurised tobacco component and one or more non-tobacco components to form a smokeless dissolvable compressed tobacco product. The step of pasteurising the tobacco component comprises direct heating of the tobacco by hot steam injection to a temperature of between about 100°C and about 120°C for a period of between about 1 minute and about 30 minutes.
- For the purposes of the invention, the total aerobic microbial count is measured in accordance with the Nordic Committee on Food Analysis (NMKL) method No 86, 4. Ed., 2006 and the total yeast and mould count specified is measured in accordance with NMKL method No 98, 4. Ed., 2005. The NMKL method No 86, 4. Ed., 2006 is used to determine the aerobic plate count by preparing a dilution series of sample material according to general microbiological principles, followed by pour-plating into an agar medium in Petri dishes, In this method, the samples are incubated under aerobic conditions at either 30°C for 3 days, 20°C for 3 days, or 6.5°C for 10 days. In the NMKL method No 98, 4. Ed., 2006, the yeast and mould count Is determined by surface inoculation of appropriate dilution series on dichloran rose bengal agar (DRBC), dichloran glycerol agar (DG18) or oxytetracykline glucose yeast extract agar (OGYE) dependent on which matrix are analysed. In this method, mould and yeast are counted after incubation at 22-25.0 +/- 1.0 °C for 5-7 days.
- The tobacco component may be pasteurised using any suitable technique provided that the pasteuriation parameters such as temperature and time are sufficient to reduce the total aerobic microbial count of the tobacco component to less than 2 log cfu/g and the total yeast and mold count of the tobacco component to less than 2 log cfu/g to render the tobacco component substantially aseptic.
- Suitable pasteurisation techniques include, but are not limited to, single hot steam injection and repeated hot steam injectionThe step of pasteurising the tobacco component comprises direct heating of the tobacco by hot steam injection to a temperature of between about 100°C and about 120°C for a period of between about 1 minute and about 30 minutes. More preferably, the step of pasteurising the tobacco component comprises direct heating of the tobacco component by repeated hot steam injection to temperatures of at least about 100°C.
- As well as reducing the total aerobic microbial count and the total yeast and mould count of the tobacco component, the heat treament of the tobacco component during pasteurisation advantageously results in the formation of tobacco-derived flavourings.
- The tobacco component may be pasteurised together with water. Alternatively, or in addition, the tobacco component may be pasteurised with one or more other additives approved for use in the food industry, including, but not limited to, sodium chloride, sodium carbonate, potassium carbonate, propylene glycol, glycerol and combinations thereof.
- The pH of the pasteurised tobacco component may be adjusted prior to compressing the pasteurised tobacco component and one or more non-tobacco components to form the smokeless dissolvable compressed tobacco product.
- Preferably, the pH of the pasteurised tobacco component is adjusted to between about 7.5 and about 8.9. The pH of the pasteurised tobacco component may be adjusted through the addition of one or more acidity regulators. Suitable acidity regulators approved for use in the food industry are known in the art and include, but are not limited to: alkali carbonates, such as sodium carbonate and potassium carbonate; calcium carbonate; alkali hydroxides, such as sodium hydroxide and potassium hydroxide; calcium hydroxide; magnesium hydroxide; and combinations thereof.
- Preferably the pH of the pasteurised tobacco component is adjusted prior to mixing the pasteurised tobacco component with the one or more non-tobacco components.
- However, alternatively or in addition, the pH of the pasteurised tobacco component may be adjusted by mixing the pasteurised tobacco component with one or more non-tobacco components comprising at least one acidity regulator or buffering agent.
- The tobacco component may comprise one or more of tobacco lamina, tobacco stem, expanded tobacco and reconstituted tobacco.
- The tobacco component may comprise a blend of two or more different types of tobacco. For example, the tobacco component may comprise a blend of two or more of different types of tobacco selected from the group consisting of Virginia, Burley, Maryland, Nicotiana rustica and oriental tobacco. Alternatively, the tobacco component may comprise a single type of tobacco.
- The tobacco component may comprise tobacco that has been one or more of dried, aged, flue-cured, air-cured, fire-cured, sun-cured, shredded, powdered and ground.
- Preferably, the tobacco component comprises air-cured tobacco, sun-cured tobacco, dark air-cured tobacco or a combination thereof.
- Preferably, the tobacco component comprises particulate tobacco. More preferably, the tobacco component comprises powdered tobacco, ground tobacco or a combination thereof.
- The particulate tobacco may have any suitable average particle size. For example, the particulate tobacco may have an average particle size of less than about 1 mm, less than about 0.5 mm or less than about 0.1 mm. Preferably, the particulate tobacco has an average particle size of between about 100 nm and about 1 mm, more preferably of between about 100 nm and about 0.5 mm. The tobacco may be ground and sieved in a typical manner in order to obtain a desired particle size.
- As well as the tobacco component, to obtain desired mechanical and organoleptic properties, smokeless dissolvable compressed tobacco products made by methods according to the invention further comprise one or more non-tobacco components. For example, smokeless dissolvable compressed tobacco products made by methods according to the invention may further comprise one or more non-tobacco components approved for use in the food industry selected from the group consisting of: acidity regulators, buffering agents, fillers, binders, gelling agents, lubricants, anti-adherents, glidants, disintegration agents, sweeteners, flavourants, taste enhancers and colourants.
- The pasteurised tobacco component may be dry blended or otherwise mixed with the one or more non-tobacco components. For example, the tobacco component and one or more non-tobacco components may be ground together or mixed in a twisting powder mixer.
- The tobacco component may be present in the smokeless dissolvable compressed tobacco product in an amount of between about 0.5% to about 60% of the dry weight of the compressed tobacco product. The amount of the tobacco component may be selected as a function of, for example, the desired nicotine content or the desired flavour or other organoleptic properties of the smokeless dissolvable compressed tobacco product.
- In a particularly preferred embodiment of the invention, the smokeless dissolvable compressed tobacco product comprises: at least one binder or filler; at least one lubricant, anti-adherent or glidant; at least one acidity regulator; at least one flavourant; and at least one sweetener. Preferably, the smokeless dissolvable compressed tobacco product also comprises one or more of a gelling agent, a taste enhancer, a colourant and a disintegration agent.
- Preferably, the smokeless dissolvable compressed tobacco product comprises at least one binder or filler. Throughout the specification, the terms "binder" and "filler" are used to refer to any component that increases the disintegration time of the dissolvable compressed tobacco product, maintains the integrity of the dissolvable compressed tobacco product, increases the hardness of the dissolvable compressed tobacco product, reduces the friability of the dissolvable compressed tobacco product or adds bulk to the smokeless dissolvable compressed tobacco product. It will be appreciated that a single non-tobacco component may perform the functions of a binder and a filler.
- The smokeless dissolvable compressed tobacco product may optionally comprise one or more gelling agents. Throughout the specification, the term "gelling agent" is used to refer to any component that affects the mouth feel of the smokeless dissolvable compressed tobacco product when dissolved in the mouth of a consumer.
- Suitable binders, fillers and gelling agents are known in the art and include, but are not limited to: non-tobacco plant fibres; starches, including pre-gelatinized starch; gums, including natural gums, such as xanthan gum, gum, acacia, gum arabic, guar gum, locust bean gum and sodium alginate; pectins: gelatine: agar: carrageenan; pullulan; microcrystalline cellulose; methyl cellulose; carboxymethyl cellulose; dextrins, including maltodextrin; sugar alcohols, such as erythritol, xylitol mannitol, sorbitol, isomalt, maltitol and lactitol; glucose; lactose; sucrose; polyvidone; calcium sulfate dihydrate; and combinations thereof.
- In a preferred embodiment, the smokeless dissolvable compressed tobacco product comprises microcrystalline cellulose, which functions as a binder and a filler.
- The smokeless dissolvable compressed tobacco product may optionally comprise one or more lubricants, anti-adherents, glidants or combinations thereof. Throughout the specification, the terms "lubricant" "anti-adherent" and "glidant" are used to refer to any component that facilitates manufacturing of the smokeless dissolvable compressed tobacco product by reducing friction, reducing adhesion, or otherwise improving flow properties. It will be appreciated that a single non-tobacco component may perform the functions of one or more of a lubricant, an anti-adherent and a glidant.
- Suitable lubricants, anti-adherents and glidants are known in the art and include, but are not limited to: stearates, including magnesium stearate, calcium stearate, sodium stearate, zinc stearate, and derivatives thereof, including sodium stearyl fumarate; fatty acids, including stearic acid; silicates, including magnesium silicates and calcium silicates; starch; lauryl sulfates, including magnesium lauryl sulfate and sodium lauryl sulfate; polyethylene glycol; and silica aerogels, including colloidal fumed silica.
- The one or more lubricants, anti-adherents, glidants or combinations thereof may be present in the smokeless dissolvable compressed tobacco product in an amount of, for example, between about 0.1% to about 5% of the dry weight of the compressed tobacco product. Preferably, the one or more lubricants, anti-adherents, glidants or combinations thereof are present in the smokeless dissolvable compressed tobacco product in an amount of less than about 1% of the dry weight of the compressed tobacco product, more preferably in an amount of about 0.2% of the dry weight of the compressed tobacco product.
- The smokeless dissolvable compressed tobacco product may optionally comprise one or more disintegrants. Throughout the specification, the term "disintegrant" is used to refer to any component that facilitates breakup or disintegration of the smokeless dissolvable compressed tobacco product when placed in a consumer's mouth.
- Suitable disintegrants are known in the art and include, but are not limited to: starches, including pregelatinised starch; sodium starch glycolate; sodium alginate; croscarmellose sodium; crosslinked polyvinylpyrrolidone, including crospovidone; sodium carboxymethyl cellulose; calcium carboxymethyl cellulose; sodium bicarbonate; and calcium carbonate.
- Depending on the nature thereof, the one or more disintegrants maybe present in the smokeless dissolvable compressed tobacco product in an amount of, for example, between about 1% to about 15% of the dry weight of the compressed tobacco product.
- The smokeless dissoluble compressed tobacco product may optionally comprise one or more sweeteners. Smokeless dissolvable compressed tobacco products made by methods according to the invention may include natural sweeteners, artificial sweeteners or combinations thereof. Suitable natural and artificial sweeteners are known in the art and include, but are not limited to: monosaccharides, such as glucose, fructose, ribose xylose and invert sugar; disaccharides, such as lactose, maltose and sucrose; sugar alcohols, such as erythritol, xylitol mannitol, sorbitol, isomalt, maltitol and lactitol; and artificial sweeteners, such as sucralose, aspartame, saccharin, acesulfame K, and cyclamate,
- Smokeless dissolvable compressed tobacco products made by methods according to the invention may optionally comprise one or more flavourants. Smokeless dissolvable compressed tobacco products made by methods according to the invention may include natural flavourants, artificial flavourants or combinations thereof. The one or more flavourants may be added in encapsulated or non-encapsulated form.
- Suitable natural and artificial flavourants are known in the art and include, but are not limited to, peppermint, spearmint, wintergreen, menthol, eucalyptus oil, angelica, anise, anethole, carvone, vanillin, vanilla, basil oil, cardamom, cassia, cinnamon, clove, cocoa, coriander oil, fennel oil, fenugreek, ginger, lemon grass, liquorice, nutmeg, palmarosa oil, sage oil, acacia, amber, clary, geranium, jasmine, juniper berry, lavender oil, magnolia, oak moss, orris root, osmanthus, rose oil, sandalwood, bergamot oil, lemon oil, lime oil, orange oil, fruit extracts, fruit flavouring, almond, coconut, chocolate, coffee, tea, arrack, rum, cognac, whisky, and gin.
- The one or more flavourants may be present in the smokeless dissolvable compressed tobacco product in an amount of, for example, between about 0.1% to about 4% of the dry weight of the compressed tobacco product.
- Smokeless dissolvable compressed tobacco products made by methods according to the invention may optionally comprise one or more taste enhancers such as, for example, sodium chloride or ammonium chloride.
- Smokeless dissolvable compressed tobacco products made by methods according to the invention may optionally comprise one or more colourants to, for example, indicate or reflect the flavour or brand of the compressed tobacco product or otherwise enhance its aesthetic appearance.
- It will be appreciated that smokeless dissolvable compressed tobacco products made by methods according to the invention may comprise multifunctional non-tobacco components that perform two or more of the functions previously described above. For example, the smokeless dissolvable compressed tobacco product may comprise a multifunctional non-tobacco component that functions as at least two of: (i) a binder or filler; (ii) a lubricant, anti-adherent or glidant; and (iii) a disintegrant. In one embodiment, the smokeless dissolvable compressed tobacco product may comprise pre-gelatinised starch that functions as a binder, lubricant and disintegrant.
- Smokeless dissolvable compressed tobacco products made by methods according to the invention may also comprise mutlifunctional non-tobacco components that perform two or more other functions. For example, the smokeless dissolvable compressed tobacco product may comprise a sugar alcohol that acts as a binder and a sweetner, or colloidal fumed silica that acts as a glidant and a desiccant. Other suitable known desiccants such as, for example, magnesium sulfate may also be included in smokeless dissolvable compressed tobacco products made by methods according to the invention to control the moisture content thereof.
- The pasteurised tobacco component may be dry blended with one or more non-tobacco components and then directly compressed in a typical manner to form the smokeless dissolvable compressed tobacco product. The pasteurised tobacco component and one or more non-tobacco components maybe be directly compressed using, for example, a tablet press having a single die and punch arrangement or a rotary tablet press having multiple dies. Prior to being dry blended with one or more non-tobacco components, the pasteurised tobacco component may optionally be wet granulated in a typical manner using, for example, a fluid bed granulator.
- The compression forces used to form the smokeless dissolvable compressed tobacco product may be selected based on a number of factors. These factors include: the type of apparatus employed to compress the tobacco component and one or more non-tobacco components; the size of the smokeless dissolvable compressed tobacco product; the desired physical and mechanical properties of the smokeless dissolvable compressed tobacco product, including but not limited to the hardness, friability, disintegration or dissolution characteristics; and the desired appearance of the compressed smokeless dissolvable compressed tobacco product. For example, through an appropriate choice of compression force and the tobacco and non-tobacco components thereof, smokeless dissolvable compressed tobacco products may be made by methods according to the invention having a hardness of between about 2 N and about 300 N.
- Furthermore, through an appropriate choice of compression force and the tobacco and non-tobacco components thereof, smokeless dissolvable compressed tobacco products may be made by methods according to the invention that dissolve in the mouth of an average consumer within about 5 minutes to about 45 minutes.
- In a preferred embodiment, through an appropriate choice of the one or more non-tobacco components therein, smokeless dissolvable compressed tobacco products may be made by methods according to the invention that dissolve in the mouth of an average consumer within about 5 minutes to about 15 minutes.
- Through another appropriate choice of the one or more non-tobacco components, smokeless dissolvable compressed tobacco products may be made by methods according to the invention which dissolve in the mouth of an average consumer within about 30 minutes to about 45 minutes and which can be sucked by a consumer and then "parked" between their cheek and gum.
- If desired, one or more surfaces of the formed smokeless dissolvable compressed tobacco product may be embossed or debossed. Alternatively the formed smokeless dissolvable compressed tobacco product may be at least partially coated in a typical manner using, for example, a pan coater.
- Smokeless dissolvable compressed tobacco products may be made by methods according to the invention in a variety of different shapes.
Figs. 1-12 show: (a) perspective views; (b) side views; and (c) top views of examples of different shaped smokeless dissolvable compressed tobacco products that may be made by methods according to the invention. - Smokeless dissolvable compressed tobacco products may also be made by methods according to the invention in a variety of different sizes. For example, smokeless dissolvable compressed tobacco products made by methods according to the invention may have a diameter of from about 2 mm to about 30 mm and a weight of from about 0.1 g to about 3.0 g.
Claims (5)
- A method of making a smokeless dissolvable compressed tobacco product comprising:pasteurising a tobacco component so as to reduce the total aerobic microbial count thereof to less than 2 log cfu/g as measured in accordance with the Nordic Committee on Food Analysis (NKML) method No 86, 4. Ed., 2006 and the total yeast and mould count thereof to less than 2 log cfu/g as measured in accordance with the Nordic Committee on Food Analysis (NKML) method No 98, 4. Ed., 2005, wherein the step of pasteurising the tobacco component comprises direct heating of the tobacco by hot steam injection to a temperature of between about 100°C and about 120°C for a period of between about 1 minute and about 30 minutes;mixing the pasteurised tobacco component with one or more non-tobacco components; andcompressing the pasteurised tobacco component and one or more non-tobacco components to form a smokeless dissolvable compressed tobacco product.
- A method according to claim 1 wherein the step of pasteurising the tobacco component comprises direct heating of the tobacco component by repeated hot steam injection to temperatures of at least about 100°C.
- A method according to claim 1 or 2 comprising:adjusting the pH of the pasteurised tobacco component to between about 7.5 and about 8.9 prior to compressing the pasteurised tobacco component and one or more non-tobacco components to form the smokeless dissolvable compressed tobacco product.
- A method according to claim 1, 2 or 3 wherein the tobacco component comprises particulate tobacco with an average particle size of between about 100 nm and about 0.5 mm.
- A method according to any of claims 1 to 4 comprising mixing the pasteurised tobacco component with one or more non-tobacco components selected from the group consisting of: acidity regulators, buffering agents, fillers, binders, gelling agents, lubricants, anti-adherents, glidants, disintegration agents, sweeteners, flavourants, taste enhancers and colourants.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09812420.9A EP2381803B1 (en) | 2009-01-28 | 2009-12-30 | Smokeless dissolvable compressed tobacco product |
| PL09812420T PL2381803T3 (en) | 2009-01-28 | 2009-12-30 | Smokeless dissolvable compressed tobacco product |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09250218A EP2213181A1 (en) | 2009-01-28 | 2009-01-28 | Smokeless dissolvable compressed tobacco product |
| PCT/EP2009/009323 WO2010086010A1 (en) | 2009-01-28 | 2009-12-30 | Smokeless dissolvable compressed tobacco product |
| EP09812420.9A EP2381803B1 (en) | 2009-01-28 | 2009-12-30 | Smokeless dissolvable compressed tobacco product |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2381803A1 EP2381803A1 (en) | 2011-11-02 |
| EP2381803B1 true EP2381803B1 (en) | 2014-06-04 |
Family
ID=40983458
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP09250218A Withdrawn EP2213181A1 (en) | 2009-01-28 | 2009-01-28 | Smokeless dissolvable compressed tobacco product |
| EP09812420.9A Active EP2381803B1 (en) | 2009-01-28 | 2009-12-30 | Smokeless dissolvable compressed tobacco product |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP09250218A Withdrawn EP2213181A1 (en) | 2009-01-28 | 2009-01-28 | Smokeless dissolvable compressed tobacco product |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20100275936A1 (en) |
| EP (2) | EP2213181A1 (en) |
| JP (1) | JP2012516137A (en) |
| KR (1) | KR101779615B1 (en) |
| BR (1) | BRPI0924206A2 (en) |
| CA (1) | CA2737323C (en) |
| DK (1) | DK2381803T3 (en) |
| EC (1) | ECSP11011291A (en) |
| MX (1) | MX2011003882A (en) |
| MY (1) | MY159762A (en) |
| PL (1) | PL2381803T3 (en) |
| RU (1) | RU2011115844A (en) |
| TW (1) | TWI513413B (en) |
| UA (1) | UA100473C2 (en) |
| WO (1) | WO2010086010A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD744160S1 (en) * | 2005-10-18 | 2015-11-24 | Swedish Match North Europe Ab | Snuff box |
| USD735054S1 (en) * | 2007-11-15 | 2015-07-28 | Swedish Match North Europe Ab | Snuff box with snuff bags |
| US10327467B2 (en) | 2010-04-14 | 2019-06-25 | Altria Client Services Llc | Preformed smokeless tobacco product |
| US11116237B2 (en) * | 2010-08-11 | 2021-09-14 | R.J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
| US9155321B2 (en) | 2010-08-11 | 2015-10-13 | R.J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
| US9204667B2 (en) * | 2010-12-01 | 2015-12-08 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products |
| US9775376B2 (en) | 2010-12-01 | 2017-10-03 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille and moulding process for forming smokeless tobacco products |
| EP2648557A1 (en) | 2010-12-10 | 2013-10-16 | Altria Client Services Inc. | Smokeless tobacco packaging system and method |
| DK2695530T3 (en) * | 2011-03-30 | 2019-01-14 | Japan Tobacco Inc | ORAL TOBACCO AND METHOD OF PRODUCING THEREOF. |
| US11944114B2 (en) * | 2012-06-20 | 2024-04-02 | Altria Client Services Llc | Smokeless tobacco lipid granules |
| US9402414B2 (en) | 2013-03-14 | 2016-08-02 | Altria Client Services Llc | Smokeless tobacco article |
| US20150096574A1 (en) * | 2013-10-03 | 2015-04-09 | Altria Client Services Inc. | Dissolvable-chewable tobacco tablet |
| CN110573032A (en) * | 2017-05-24 | 2019-12-13 | 菲利普莫里斯生产公司 | Heated aerosol-generating article comprising homogenized vegetable material |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2739600A (en) * | 1955-07-01 | 1956-03-27 | American Mach & Foundry | Tobacco treatment |
| US4513756A (en) * | 1983-04-28 | 1985-04-30 | The Pinkerton Tobacco Company | Process of making tobacco pellets |
| GB2142822B (en) * | 1983-06-29 | 1987-02-11 | Alec Stanley Walter Shaw | Nicotine lozenges |
| US4624269A (en) * | 1984-09-17 | 1986-11-25 | The Pinkerton Tobacco Company | Chewable tobacco based product |
| US5372149A (en) * | 1992-03-25 | 1994-12-13 | Roth; David S. | Sterilization process in the manufacturing of snuff |
| US5549906A (en) * | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
| OA12601A (en) * | 2001-05-01 | 2006-06-09 | Jonnie R Williams | Smokeless tobacco product. |
| US20040020503A1 (en) * | 2001-05-01 | 2004-02-05 | Williams Jonnie R. | Smokeless tobacco product |
| US6668839B2 (en) * | 2001-05-01 | 2003-12-30 | Jonnie R. Williams | Smokeless tobacco product |
| WO2005046363A2 (en) * | 2003-11-07 | 2005-05-26 | U.S. Smokeless Tobacco Company | Tobacco compositions |
| US8627828B2 (en) * | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
| US7918231B2 (en) * | 2006-01-31 | 2011-04-05 | U.S. Smokeless Tobacco Company Llc | Tobacco articles and methods |
| US7810507B2 (en) * | 2006-02-10 | 2010-10-12 | R. J. Reynolds Tobacco Company | Smokeless tobacco composition |
| US7946296B2 (en) * | 2006-05-26 | 2011-05-24 | Philip Morris Usa Inc. | Dissolvable tobacco film strips and method of making the same |
| US20080029116A1 (en) * | 2006-08-01 | 2008-02-07 | John Howard Robinson | Smokeless tobacco |
| ATE489858T1 (en) * | 2006-08-01 | 2010-12-15 | Reynolds Tobacco Co R | SMOKELESS TOBACCO |
| BRPI0719428A2 (en) * | 2006-12-01 | 2014-02-25 | Cima Labs Inc | SOLID ORAL TRANSMUCOSAL DOSAGE FORM, METHOD FOR TREATING NICOTINE DEPENDENCE IN A RECEIVER WISHING SUCH TREATMENT, ORAL TRANSMUCOSAL NICOTINE DISTRIBUTION, AND NICOTINE REPLACEMENT METHOD. |
| TW200901904A (en) * | 2007-02-23 | 2009-01-16 | Us Smokeless Tobacco Co | Novel tobacco compositions and methods of making |
| US9125434B2 (en) * | 2007-10-11 | 2015-09-08 | Philip Morris Products S.A. | Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet |
| US8336557B2 (en) * | 2007-11-28 | 2012-12-25 | Philip Morris Usa Inc. | Smokeless compressed tobacco product for oral consumption |
| RU2449717C2 (en) * | 2007-12-21 | 2012-05-10 | Свидиш Мэтч Норт Юроп Аб | Tobacco or non-tobacco product containing magnesium carbonate |
-
2009
- 2009-01-28 EP EP09250218A patent/EP2213181A1/en not_active Withdrawn
- 2009-12-30 CA CA2737323A patent/CA2737323C/en active Active
- 2009-12-30 JP JP2011546617A patent/JP2012516137A/en active Pending
- 2009-12-30 WO PCT/EP2009/009323 patent/WO2010086010A1/en active Application Filing
- 2009-12-30 BR BRPI0924206A patent/BRPI0924206A2/en not_active Application Discontinuation
- 2009-12-30 KR KR1020117007485A patent/KR101779615B1/en active IP Right Grant
- 2009-12-30 DK DK09812420.9T patent/DK2381803T3/en active
- 2009-12-30 PL PL09812420T patent/PL2381803T3/en unknown
- 2009-12-30 EP EP09812420.9A patent/EP2381803B1/en active Active
- 2009-12-30 MX MX2011003882A patent/MX2011003882A/en active IP Right Grant
- 2009-12-30 RU RU2011115844/12A patent/RU2011115844A/en unknown
- 2009-12-30 UA UAA201110288A patent/UA100473C2/en unknown
- 2009-12-30 MY MYPI2011000757A patent/MY159762A/en unknown
-
2010
- 2010-01-26 TW TW099102062A patent/TWI513413B/en not_active IP Right Cessation
- 2010-01-28 US US12/695,697 patent/US20100275936A1/en not_active Abandoned
-
2011
- 2011-08-26 EC EC2011011291A patent/ECSP11011291A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY159762A (en) | 2017-01-31 |
| PL2381803T3 (en) | 2014-11-28 |
| MX2011003882A (en) | 2011-05-19 |
| TWI513413B (en) | 2015-12-21 |
| WO2010086010A1 (en) | 2010-08-05 |
| CA2737323C (en) | 2016-06-21 |
| BRPI0924206A2 (en) | 2016-01-19 |
| RU2011115844A (en) | 2013-03-10 |
| DK2381803T3 (en) | 2014-07-14 |
| KR20110110762A (en) | 2011-10-07 |
| UA100473C2 (en) | 2012-12-25 |
| KR101779615B1 (en) | 2017-10-10 |
| TW201036559A (en) | 2010-10-16 |
| ECSP11011291A (en) | 2011-09-30 |
| US20100275936A1 (en) | 2010-11-04 |
| JP2012516137A (en) | 2012-07-19 |
| EP2213181A1 (en) | 2010-08-04 |
| CA2737323A1 (en) | 2010-08-05 |
| EP2381803A1 (en) | 2011-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2381803B1 (en) | Smokeless dissolvable compressed tobacco product | |
| US20230097809A1 (en) | Oral product | |
| EP3518691B1 (en) | Tobacco beads | |
| US11612183B2 (en) | Protein-enriched tobacco composition | |
| EP4027813B1 (en) | Oral product with a basic amine and an ion pairing agent | |
| EP2613653B1 (en) | Smokeless tobacco product comprising effervescent composition | |
| EP2512271B1 (en) | Tobacco product and method for manufacture | |
| US20180070626A1 (en) | Oral tobacco product | |
| US20230210836A1 (en) | Moist oral compositions | |
| US20190223490A1 (en) | Tobacco lozenge | |
| US20210169132A1 (en) | Oral composition including gels | |
| US20110139164A1 (en) | Tobacco Product And Method For Manufacture | |
| EP3052081B1 (en) | Lozenge | |
| US20210169788A1 (en) | Oral product and method of manufacture | |
| US20230270863A1 (en) | Oral products with reduced irritation | |
| US20210169137A1 (en) | Pouched products | |
| US20210169785A1 (en) | Oral compositions with reduced water activity | |
| US20210169868A1 (en) | Oral compositions with reduced water content | |
| US20230200430A1 (en) | Oral products with high-density load | |
| US20210169784A1 (en) | Buffered oral compositions | |
| WO2022229926A1 (en) | Multi-compartment oral pouched product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20110624 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20130422 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| INTG | Intention to grant announced |
Effective date: 20140306 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 670520 Country of ref document: AT Kind code of ref document: T Effective date: 20140615 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: BOVARD AG, CH |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20140710 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602009024514 Country of ref document: DE Effective date: 20140717 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
| REG | Reference to a national code |
Ref country code: NO Ref legal event code: T2 Effective date: 20140604 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 670520 Country of ref document: AT Kind code of ref document: T Effective date: 20140604 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140905 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 |
|
| REG | Reference to a national code |
Ref country code: PL Ref legal event code: T3 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141006 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141004 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602009024514 Country of ref document: DE |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 |
|
| 26N | No opposition filed |
Effective date: 20150305 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602009024514 Country of ref document: DE Effective date: 20150305 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141230 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20150831 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141230 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141231 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20091230 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20151230 Year of fee payment: 7 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140604 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20191122 Year of fee payment: 11 Ref country code: DK Payment date: 20191227 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NO Payment date: 20191223 Year of fee payment: 11 |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP Effective date: 20201231 |
|
| REG | Reference to a national code |
Ref country code: NO Ref legal event code: MMEP |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201231 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201231 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201230 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201230 |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230529 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231220 Year of fee payment: 15 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20231220 Year of fee payment: 15 Ref country code: NL Payment date: 20231220 Year of fee payment: 15 Ref country code: DE Payment date: 20231214 Year of fee payment: 15 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20240101 Year of fee payment: 15 |